Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events

Hypercholesterolemia and hypertension are among the most important risk factors for cardiovascular (CV) disease. They are also important contributors to metabolic diseases including diabetes that further increase CV risk. Updated guidelines emphasize targeted reduction of overall CV risks but do not...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Kwang Kon, Sakuma, Ichiro, Shimada, Kazunori, Hayashi, Toshio, Quon, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537141/
https://www.ncbi.nlm.nih.gov/pubmed/28765731
http://dx.doi.org/10.4070/kcj.2016.0406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537141/
https://www.ncbi.nlm.nih.gov/pubmed/28765731
http://dx.doi.org/10.4070/kcj.2016.0406

Ejemplares similares